The Parexel-Microsoft partnership announced in October has reaped its first crop: Perceptive Cloud, a cloud platform with Parexel’s informatics solutions now built on the enhanced cloud infrastructure ...

BOSTON, Jan. 22, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has selected Xavier Flinois to ...

BOSTON & DURHAM, N.C.--(BUSINESS WIRE)--Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical ...

In a recent press release from Microsoft Corp. and PAREXEL International Corp., a leading global biopharmaceutical services organization, on Tuesday announced a technology development alliance aimed ...

BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of its patient sensor solution, a new ...

“As clinical studies become more complex, there is a growing need for real-time and standardized data and analytics from multiple studies,” said Xavier Flinois, President, PAREXEL Informatics. “Using ...

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched the next generation of its Perceptive MyTrials ® platform with advanced analytics ...

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched next generation risk-based monitoring capabilities, expanding its Perceptive ...

BOSTON, Aug. 2, 2012 /PRNewswire/ -- PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global consultancy serving the biopharmaceutical and medical device ...

While current technology has promised to accelerate the design and execution of clinical trials, the increased adoption of individual applications creates new integration challenges and workflow ...